Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes
- 26 July 2005
- journal article
- research article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 59 (9) , 1039-1044
- https://doi.org/10.1111/j.1742-1241.2005.00546.x
Abstract
Diminished oestrogen receptor (ER) expression in the involved axillary lymph nodes (ALN) in breast cancer compared with the primary tumour has been reported in previous studies. We have assessed a wider spectrum of tumour markers (ER, progesterone receptor (PgR), p53, Ki-67 and HER-2/neu) and compared extent and staining intensities at the primary tumour and the involved ALN on specimens of 22 cases with invasive ductal breast cancer. At the involved ALN, both the quantity of positive staining cells and the staining intensities for ER and PgR were decreased (p < 0.001 and p = 0.003, respectively). In contrast, the quantity of positive staining cells (p < 0.004) and the staining intensities for Ki-67 were increased. The differences for HER-2/neu and p53 staining at both sites were insignificant. The immunohistochemical staining properties of both the primary tumour and the ALN metastases showed no correlation with the number of involved ALN (p > 0.05). This study suggested that ALN metastasis might indicate a more unfavourable expression pattern of ER, PgR and Ki-67 in invasive ductal breast cancer.Keywords
This publication has 19 references indexed in Scilit:
- Pathology of breast carcinomaInternational Journal Of Clinical Practice, 2004
- From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progressionProceedings of the National Academy of Sciences, 2003
- The future of cytotoxic therapy: selective cytotoxicity based on biology is the keyBreast Cancer Research, 2003
- Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node‐positive breast cancer and its implications in patient outcomeJournal of Surgical Oncology, 2003
- Prognostic and Predictive Indicators in Operable Breast CancerClinical Breast Cancer, 2003
- Molecular prognostic factors for breast cancer metastasis and survivalSeminars in Radiation Oncology, 2002
- Premenopausal Breast CancerDrugs, 2002
- Recent advances in breast cancer biologyCurrent Opinion in Oncology, 1996
- Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67Breast Cancer Research and Treatment, 1991
- Heterogeneity of soluble and nuclear oestrogen receptor status of involved nodes in relation to primary breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987